Wolfe Research analyst Justin Lake downgraded Oak Street Health (OSH) to Peer Perform from Outperform without a price target citing the pending takeover by CVS Health (CVS). The firm expects the deal to close in 2023.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on OSH:
- Oak Street Health downgraded to Market Perform from Outperform at TD Cowen
- Oak Street Health reports FY22 revenue $2.16B, consensus $2.15B
- Oak Street Health downgraded to Neutral from Overweight at JPMorgan
- Oak Street Health downgraded to Market Perform from Outperform at Bernstein
- Oak Street Health downgraded to Market Perform from Outperform at Raymond James